Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020

Trevor A. Crowell; Ibrahim I. Daud; Jonah Maswai; John Owuoth; Valentine Sing'Oei; Michelle Imbach; Nicole Dear; Fred Sawe; Leigh Anne Eller; Christina S. Polyak; Julie A. Ake

doi:10.1097/QAD.0000000000003054

Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020

Trevor A. Crowell^*
, Ibrahim I. Daud
, Jonah Maswai
, John Owuoth
, Valentine Sing'Oei
, Michelle Imbach
, Nicole Dear
, Fred Sawe
, Leigh Anne Eller
, Christina S. Polyak
, Julie A. Ake

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.

Original language	English
Pages (from-to)	2401-2404
Number of pages	4
Journal	AIDS
Volume	35
Issue number	14
DOIs	https://doi.org/10.1097/QAD.0000000000003054
State	Published - 15 Nov 2021
Externally published	Yes

Access to Document

10.1097/QAD.0000000000003054

Cite this

@article{5109ed106bd44132a83a58e8c196cc8d,

title = "Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020",

abstract = "Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3\%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1\% vs. 4\%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.",

author = "Crowell, \{Trevor A.\} and Daud, \{Ibrahim I.\} and Jonah Maswai and John Owuoth and Valentine Sing'Oei and Michelle Imbach and Nicole Dear and Fred Sawe and Eller, \{Leigh Anne\} and Polyak, \{Christina S.\} and Ake, \{Julie A.\}",

year = "2021",

month = nov,

day = "15",

doi = "10.1097/QAD.0000000000003054",

language = "English",

volume = "35",

pages = "2401--2404",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "14",

}

TY - JOUR

T1 - Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020

AU - Crowell, Trevor A.

AU - Daud, Ibrahim I.

AU - Maswai, Jonah

AU - Owuoth, John

AU - Sing'Oei, Valentine

AU - Imbach, Michelle

AU - Dear, Nicole

AU - Sawe, Fred

AU - Eller, Leigh Anne

AU - Polyak, Christina S.

AU - Ake, Julie A.

PY - 2021/11/15

Y1 - 2021/11/15

N2 - Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.

AB - Among 582 participants in Western Kenya who were retrospectively tested from January through March 2020, 19 (3.3%) had detectable SARS-CoV-2 antibodies. The prevalence of detectable SARS-CoV-2 antibodies was similar between participants with and without HIV (3.1% vs. 4%, P = 0.68). One participant reported a cough in the preceding week but others denied symptoms. These may represent cross-reactivity or asymptomatic infections that predated the first reported COVID-19 cases in Kenya.

UR - https://www.scopus.com/pages/publications/85121407964

U2 - 10.1097/QAD.0000000000003054

DO - 10.1097/QAD.0000000000003054

M3 - Review article

C2 - 34482354

AN - SCOPUS:85121407964

SN - 0269-9370

VL - 35

SP - 2401

EP - 2404

JO - AIDS

JF - AIDS

IS - 14

ER -

Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020

Abstract

Access to Document

Fingerprint

Cite this